Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VOTIS Subdermal Imaging Technologies, Ltd. logo — VOTIS-a revolutionary medical device to safely screen, stage...

VOTIS Subdermal Imaging Technologies, Ltd.

VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!

Founded 2017 Israel Israel 17 employees Seed Total: $4.77M Biotechnology, Health Care +1

General Information

Company Name VOTIS Subdermal Imaging Technologies, Ltd.
Founded Year 2017
Location Israel Israel +1
Founders / Decision Makers
Team member
Employees 17
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when VOTIS Subdermal Imaging Technologies, Ltd. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VOTIS Subdermal Imaging Technologies, Ltd.

VOTIS Subdermal Imaging Technologies is a biotechnology and healthcare startup based in Israel, founded in 2017. The company offers a revolutionary medical device, with the slogan "VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!" VOTIS provides clinical decision support for the diagnosis and monitoring of diabetic foot syndrome and related conditions. The device is designed for safe and repeated use over time, as well as for acute use during surgical procedures. The process is non-invasive and ionizing-radiation-free, providing objective, repeatable, and measurable data useful to the doctor — regardless of treatment options being used. The startup recently received a $2.27M Seed Round investment on 21 April 2023 from Italian Angels for Growth. This investment serves as an indication of the confidence that the investing firm has in VOTIS and its potential within the medical technology space. This significant investment will likely be utilized for further research and development, market expansion, and potential regulatory approvals. Overall, VOTIS Subdermal Imaging Technologies is poised to make a substantial impact in the healthcare industry, particularly in the management of diabetic foot syndrome, and with the recent investment, it is well-positioned for future growth and success.

Taxonomy: medical device, diabetic foot, clinical decision support, non-invasive, peripheral vascular disease, Subdermal Imaging Technologies, early screening, healthcare costs, surgical procedures, ionizing-radiation-free, objective data, reducing amputation incidents, monitoring device, health technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
21 Apr 2023
Seed Round •••••• - 01 Jun 2021
Non Equity Assistance •••••• 1
Investor
01 Nov 2017

VOTIS Subdermal Imaging Technologies, Ltd. Alternatives & Competitors

VOTIS Subdermal Imaging Technologies, Ltd. vs
Flyte
Flyte

Innovative femtech solutions empowering women to combat bladder leaks and strengthen pelvic floor mu...

Seed
2-10 employees
Health Care, Women's Health
VOTIS Subdermal Imaging Technologies, Ltd. vs
Canopy
Canopy United States

Remote monitoring and management software for kiosks, security systems, POS solutions and other conn...

Series Unknown
37 employees
Information Technology
VOTIS Subdermal Imaging Technologies, Ltd. vs
Sana Health
Sana Health United States

Relief made possible. Sana guides users into a deep state of relaxation, accelerating physical and m...

Convertible Note
24 employees
Consumer Electronics, Hardware

FAQ About VOTIS Subdermal Imaging Technologies, Ltd.

VOTIS-a revolutionary medical device to safely screen, stage and monitor the diabetic foot. We help you keep your feet!
VOTIS Subdermal Imaging Technologies, Ltd. was founded in 2017.
VOTIS Subdermal Imaging Technologies, Ltd. is headquartered in Israel.
VOTIS Subdermal Imaging Technologies, Ltd. operates in the following industries: Biotechnology, Health Care, Medical Devices.
VOTIS Subdermal Imaging Technologies, Ltd. has approximately 17 employees.
VOTIS Subdermal Imaging Technologies, Ltd. has completed 3 funding rounds, raising a total of $4.77M. The latest funding stage is Seed.
Top alternatives and competitors to VOTIS Subdermal Imaging Technologies, Ltd. include Flyte, Canopy, Sana Health, Mobile Guardian 🏫 ☁️📲, Gupshup. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VOTIS Subdermal Imaging Technologies, Ltd. and Flyte are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors VOTIS Subdermal Imaging Technologies, Ltd. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes